老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.09
-0.0600-5.22%
盘前：1.120.0300+2.75%08:22 EDT
成交量：10.03万
成交额：11.10万
市值：1,400.99万
市盈率：-1.00
高：1.15
开：1.14
低：1.08
收：1.15
数据加载中...
总览公司新闻公告
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/07/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多